Agilent Technologies, Inc. (A)

Market Cap	39.27B
Revenue (ttm)	6.95B
Net Income (ttm)	1.30B
Shares Out	283.50M
EPS (ttm)	4.57
PE Ratio	30.31
Forward PE	23.29
Dividend	$1.02 (0.74%)
Ex-Dividend Date	Jan 6, 2026

Volume	2,038,265
Open	137.62
Previous Close	137.24
Day's Range	137.21 - 139.19
52-Week Range	96.43 - 160.27
Beta	1.27
Analysts	Buy
Price Target	162.80 (+17.53%)
Earnings Date	Nov 24, 2025

About A

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnosti...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Nov 18, 1999
• Employees: 18,100
• Stock Exchange: NYSE
• Ticker Symbol: A
• Website: https://www.agilent.com

Financial Performance

In 2025, Agilent Technologies's revenue was $6.95 billion, an increase of 6.73% compared to the previous year's $6.51 billion. Earnings were $1.30 billion, an increase of 1.09%.

Analyst Summary

According to 15 analysts, the average rating for A stock is "Buy." The 12-month stock price target is $162.8, which is an increase of 17.53% from the latest price.

Price Target

$162.8

(17.53% upside)

Analyst Consensus: Buy